(Q48374043)

11 February 2018

title

Tardive dyskinesia and serum iron indices. (English)

1 reference

11 February 2018

1 reference

Wirshing DA

1

1 reference

11 February 2018

Bartzokis G

2

1 reference

11 February 2018

Pierre JM

3

1 reference

11 February 2018

Wirshing WC

4

1 reference

11 February 2018

Sun A

5

1 reference

11 February 2018

Tishler TA

6

1 reference

11 February 2018

Marder SR

7

1 reference

11 February 2018

language of work or name

English

0 references

publication date

1 September 1998

1 reference

11 February 2018

published in

Biological Psychiatry

1 reference

11 February 2018

volume

44

1 reference

11 February 2018

issue

6

1 reference

11 February 2018

page(s)

493-498

1 reference

11 February 2018

Vitamin E treatment of tardive dyskinesia

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Nutritional iron and dopamine binding sites in the rat brain

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

A rating scale for drug-induced akathisia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Magnetic resonance imaging evaluation of brain iron levels

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

MRI in tardive dyskinesia: shortened left caudate T2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Field dependent transverse relaxation rate increase may be a specific measure of tissue iron stores.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

MR evaluation of age-related increase of brain iron in young adult and older normal males

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Neuroleptic-induced supersensitivity and brain iron: I. Iron deficiency and neuroleptic-induced dopamine D2 receptor supersensitivity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Typical and atypical neuroleptics induce alteration in blood-brain barrier and brain 59FeCl3 uptake.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Low serum iron status and akathisia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Basal ganglia T2 relaxation times in schizophrenia: a quantitative magnetic resonance imaging study in relation to tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Possible involvement of free radicals in neuroleptic-induced movement disorders. Evidence from treatment of tardive dyskinesia with vitamin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Staining intensity of brain iron in patients with schizophrenia: a postmortem study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Brain iron in the rat: extremely slow turnover in normal rats may explain long-lasting effects of early iron deficiency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Chlorpromazine stimulatory effect on iron uptake by rat brain synaptosomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

An autoradiographic study of the uptake and distribution of iron by the brain of the young rat.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Treatment of tardive dyskinesia with vitamin E.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Vitamin E in the treatment of tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Basal ganglia iron in tardive dyskinesia: an MRI study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

The effect of age on the non-haemin iron in the human brain.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Neuropathological findings in three cases of persistent dyskinesia following phenothiazine medication

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Day-to-day variation in iron status indexes is similar for most measures in elderly women with and without rheumatoid arthritis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Vitamin E in the treatment of tardive dyskinesia: the possible involvement of free radical mechanisms

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Two-year outcome of social skills training and group psychotherapy for outpatients with schizophrenia.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Tardive dyskinesia, lipid peroxidation, and sustained amelioration with vitamin E treatment

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Neuroleptic-induced movement disorders and body iron status

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

The neuropsychiatry of brain iron.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

High stored iron levels are associated with excess risk of myocardial infarction in eastern Finnish men.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Cohort study of relation between donating blood and risk of myocardial infarction in 2682 men in eastern Finland

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

T1 and T2 of ferritin solutions: effect of loading factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Effect of chlorphromazine on central nervous system concentrations of manganese, iron, and copper

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

A 10-year follow-up study of tardive dyskinesia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

Putative biological mechanisms of the effect of iron deficiency on brain biochemistry and behavior.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-3223%2897%2900453-8

10.1016/S0006-3223(97)00453-8

7 January 2021

Identifiers

DOI

1 reference

11 February 2018

1 reference

11 February 2018